Is Allakos Stock a Good Investment?
Allakos Investment Advice | ALLK |
- Examine Allakos' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Allakos' leadership team and their track record. Good management can help Allakos navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Allakos' business and its evolving consumer preferences.
- Compare Allakos' performance and market position to its competitors. Analyze how Allakos is positioned in terms of product offerings, innovation, and market share.
- Check if Allakos pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Allakos' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Allakos stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Allakos is a good investment.
Sell | Buy |
Hold
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Allakos Stock
Researching Allakos' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 95.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.38. Some equities with similar Price to Book (P/B) outperform the market in the long run. Allakos has Price/Earnings To Growth (PEG) ratio of 0.09. The entity recorded a loss per share of 2.03. The firm had not issued any dividends in recent years.
To determine if Allakos is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Allakos' research are outlined below:
| Allakos generated a negative expected return over the last 90 days | |
| Allakos has high historical volatility and very poor performance | |
| Allakos has some characteristics of a very speculative penny stock | |
| Allakos has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (185.7 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Allakos currently holds about 212.44 M in cash with (116.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.87, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Allakos has a frail financial position based on the latest SEC disclosures | |
| Over 95.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Lycia Therapeutics Announces the Appointment of Chin Lee, MD, MPH, as Chief Medical Officer and Reveals Immunology Pipeline |
Allakos Quarterly Accounts Payable |
|
Allakos uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Allakos. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Allakos' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Allakos' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Allakos' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-11 | 2024-09-30 | -0.25 | -0.21 | 0.04 | 16 | ||
2019-03-14 | 2018-12-31 | -0.31 | -0.35 | -0.04 | 12 | ||
2019-11-12 | 2019-09-30 | -0.42 | -0.47 | -0.05 | 11 | ||
2023-11-13 | 2023-09-30 | -0.45 | -0.52 | -0.07 | 15 | ||
2023-08-09 | 2023-06-30 | -0.48 | -0.41 | 0.07 | 14 | ||
2023-03-06 | 2022-12-31 | -0.57 | -0.5 | 0.07 | 12 | ||
2018-11-08 | 2018-09-30 | -0.24 | -0.34 | -0.1 | 41 | ||
2019-05-08 | 2019-03-31 | -0.33 | -0.47 | -0.14 | 42 |
Know Allakos' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Allakos is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Allakos backward and forwards among themselves. Allakos' institutional investor refers to the entity that pools money to purchase Allakos' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Point72 Asset Management, L.p. | 2024-09-30 | 1.8 M | Blackrock Inc | 2024-09-30 | 1.3 M | Rock Springs Capital Management Lp | 2024-09-30 | 1.2 M | Millennium Management Llc | 2024-09-30 | 1 M | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 996.4 K | Geode Capital Management, Llc | 2024-09-30 | 988.2 K | Ikarian Capital, Llc | 2024-12-31 | 972 K | Deutsche Bank Ag | 2024-09-30 | 913 K | Barclays Plc | 2024-09-30 | 870 K | Bvf Inc | 2024-12-31 | 16.6 M | Nea Management Company, Llc | 2024-12-31 | 6.1 M |
Allakos' market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 27.72 M.Market Cap |
|
Allakos' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.88) | (0.92) | |
| Return On Capital Employed | (1.09) | (1.14) | |
| Return On Assets | (0.88) | (0.92) | |
| Return On Equity | (1.27) | (1.20) |
Determining Allakos' profitability involves analyzing its financial statements and using various financial metrics to determine if Allakos is a good buy. For example, gross profit margin measures Allakos' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Allakos' profitability and make more informed investment decisions.
Evaluate Allakos' management efficiency
Allakos has return on total asset (ROA) of (0.4875) % which means that it has lost $0.4875 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2168) %, meaning that it created substantial loss on money invested by shareholders. Allakos' management efficiency ratios could be used to measure how well Allakos manages its routine affairs as well as how well it operates its assets and liabilities. The value of Return On Tangible Assets is estimated to slide to -0.92. The value of Return On Capital Employed is expected to slide to -1.14. At this time, Allakos' Total Current Liabilities is quite stable compared to the past year. Liabilities And Stockholders Equity is expected to rise to about 370.4 M this year, although the value of Change To Liabilities is projected to rise to (8.3 M).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.75 | 1.66 | |
| Tangible Book Value Per Share | 1.75 | 1.66 | |
| Enterprise Value Over EBITDA | (1.00) | (1.05) | |
| Price Book Value Ratio | 1.26 | 1.33 | |
| Enterprise Value Multiple | (1.00) | (1.05) | |
| Price Fair Value | 1.26 | 1.33 | |
| Enterprise Value | 486.8 M | 784.5 M |
The decision-making processes within Allakos are key to its success in a competitive market. By evaluating these processes, we assess the stock's potential for future gains.
Beta 0.771 |
Basic technical analysis of Allakos Stock
As of the 19th of February, Allakos shows the Standard Deviation of 12.3, risk adjusted performance of (0.03), and Mean Deviation of 6.24. Allakos technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Allakos' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Allakos insiders, such as employees or executives, is commonly permitted as long as it does not rely on Allakos' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Allakos insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Allakos' Outstanding Corporate Bonds
Allakos issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Allakos uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Allakos bonds can be classified according to their maturity, which is the date when Allakos has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand Allakos' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Allakos' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | 0.9044 | |||
| Mean Deviation | 6.24 | |||
| Coefficient Of Variation | (1,644) | |||
| Standard Deviation | 12.3 | |||
| Variance | 151.41 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.75) | |||
| Total Risk Alpha | (1.01) | |||
| Treynor Ratio | 0.8944 | |||
| Maximum Drawdown | 109.24 | |||
| Value At Risk | (8.67) | |||
| Potential Upside | 15.38 | |||
| Skewness | (3.84) | |||
| Kurtosis | 27.09 |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | 0.9044 | |||
| Mean Deviation | 6.24 | |||
| Coefficient Of Variation | (1,644) | |||
| Standard Deviation | 12.3 | |||
| Variance | 151.41 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.75) | |||
| Total Risk Alpha | (1.01) | |||
| Treynor Ratio | 0.8944 | |||
| Maximum Drawdown | 109.24 | |||
| Value At Risk | (8.67) | |||
| Potential Upside | 15.38 | |||
| Skewness | (3.84) | |||
| Kurtosis | 27.09 |
Consider Allakos' intraday indicators
Allakos intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Allakos stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Allakos time-series forecasting models is one of many Allakos' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Allakos' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Allakos Stock media impact
Far too much social signal, news, headlines, and media speculation about Allakos that are available to investors today. That information is available publicly through Allakos media outlets and privately through word of mouth or via Allakos internal channels. However, regardless of the origin, that massive amount of Allakos data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Allakos news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Allakos relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Allakos' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Allakos alpha.
Allakos Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Allakos can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Allakos Corporate Management
| Alan Chang | Director Analytics | Profile | |
| Brad Youngblood | Head Research | Profile | |
| Craig MD | Chief Officer | Profile | |
| Henrik Rasmussen | Chief Medical Officer | Profile | |
| Baird III | Chief Officer | Profile | |
| Mary Cromwell | Chief Officer | Profile |
Already Invested in Allakos?
The danger of trading Allakos is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Allakos is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Allakos. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Allakos is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Allakos is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Allakos Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Allakos Stock. Highlighted below are key reports to facilitate an investment decision about Allakos Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Allakos. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Allakos Stock please use our How to buy in Allakos Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Allakos. If investors know Allakos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Allakos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Allakos is measured differently than its book value, which is the value of Allakos that is recorded on the company's balance sheet. Investors also form their own opinion of Allakos' value that differs from its market value or its book value, called intrinsic value, which is Allakos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Allakos' market value can be influenced by many factors that don't directly affect Allakos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Allakos' value and its price, as these two are different measures arrived at by various means. Investors typically determine if Allakos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Allakos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.